Chronic Myeloproliferative Disorders Completed Phase 1 Trials for Cladribine (DB00242)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004904Stem Cell Transplantation in Treating Patients With Hematologic CancerTreatment